论文部分内容阅读
盐酸芦氟沙星（ｒｕｆｌｏｘａｃｉｎ）是新一代喹诺酮类广谱抗菌新药，１９８５年由意大利ｍｅｄｉｏｌａｎｕｍ公司研制，１９９２年在该国首先上市，我国由武汉滨湖制药厂率先研制成功。其特点为抗菌谱广，血浆半衰期长，每天只需给药１次，在组织、器官和体液中药物浓度高
Rufloxacin hydrochloride is a new generation of quinolone broad-spectrum antibacterial new drug. It was developed by mediolanum company in Italy in 1985 and first listed in the country in 1992. Our country was first developed successfully by Wuhan Binhu Pharmaceutical Factory. It is characterized by broad antibacterial spectrum, long half-life of plasma, administered only once a day, high concentrations of drugs in tissues, organs and body fluids